contact & imprint





Arianna Novati

Stefanie Flunkert

CHDI Therapeutics in Palm Springs, February 24-27, 2014

Arianna Novati

Libo Yu-Tager

Laura Clemens

Huu Phuc Nguyen

European HD network meeting in Barcelona, Septemer 19-21, 2014

Laura Clemens

Measuring Behavior Meeting in Wageningen, August 27-29, 2014

Huu Phuc Nguyen

HD Insights (Huntington’s Disease research periodical for the HD community)



Reduced Motivation in the BACHD Rat Model of Huntington Disease Is Dependent on the Choice of Food Deprivation Strategy

Jansson EK , Clemens LE, Riess O, Nguyen HP, 2014. PLoS ONE, 8: e105662. Doi:10.1371/journal.pone.0105662

Further investigation of phenotypes and confounding factors of progressive ratio performance and feeding behavior in the BACHD rat model of Huntington disease

Clemensson EK , Clemensson LE, Fabry B, Riess O, Nguyen HP, 2017. PLoS ONE, 8: e173232 Doi:10.1371/journal.pone.0173232

Dysregulation of gene expression in the striatum of BACHD rats expressing full-lenght mutant huntingtin and associated abnormalities on molecular and protein levels

Yu-Taeger L , Bonin M, Stricker-Shaver J, Riess O, Nguyen HP, 2017. Neuropharmacology, 5: Doi:10.1016/j.neuropharm.2017.01.029.

The BACHD rat model of Huntington disease shows signs of fronto-striatal dysfunction in two operant conditioning tests of short-term memory

Clemensson EK , Clemensson LE, Riess O, Nguyen HP, 2017. PLoS ONE, 1: e0169051 Doi:10.1371/journal.pone.01609051

Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease

Teo RT, Hong X, Yu-Taeger L, Huang Y, Tan LJ, Xie Y, To XV, Guo L, Rajendran R, Novati A, Calaminus C, Riess O, Hayden MR, Nguyen HP, Chuang KH, Pouladi MA, 2016. Hum Mol Genet., 7:

SwitchHD is funded from the European Community’s Seventh Framework Programme FP7/2012 under grant agreement No. 324495
Marie Curie Actions Logo